Ankyrin is the major oxidised protein in erythrocyte membranes from end-stage renal disease patients on chronic haemodialysis and oxidation is decreased by dialysis and vitamin C supplementation

作者: T. Ruskovska , S. J Bennett , C. R. Brown , S. Dimitrov , N. Kamcev

DOI: 10.3109/10715762.2014.991725

关键词:

摘要: Chronically haemodialysed end-stage renal disease patients are at high risk of morbidity arising from complications dialysis, the underlying pathology that has led to and complex chronic kidney disease. Anaemia is commonplace its origins multifactorial, involving reduced erythropoietin production, accumulation uremic toxins an increase in erythrocyte fragility. Oxidative damage a common factor co-morbidities known cause Therefore, we have investigated hypothesis specific membrane proteins more oxidised vitamin C supplementation can ameliorate protein oxidation. Eleven 15 control subjects were recruited study. Patients supplemented with 2 × 500 mg per day for 4 weeks. Erythrocyte prepared pre- post-vitamin determination Total carbonyls by but not dialysis when enzyme linked immunosorbent assay. Using western blot detect proteins, one band, later identified as containing ankyrin, was found be controls significantly 60% all after 20% treatment pre-dialysis. Ankyrin oxidation analysis may useful stratified medicines approach possible marker identify requirements intervention patients.

参考文章(53)
Mohammad Kamgar, Frank Zaldivar, Nosratola D. Vaziri, Madeleine V. Pahl, Antioxidant therapy does not ameliorate oxidative stress and inflammation in patients with end-stage renal disease. Journal of The National Medical Association. ,vol. 101, pp. 336- 344 ,(2009) , 10.1016/S0027-9684(15)30881-6
Nathorn Chaiyakunapruk, Visanu Thamlikitkul, Brad Einerson, Sirada Maphanta, Chagriya Kitiyakara, The Efficacy of Ascorbic Acid in Suboptimal Responsive Anemic Hemodialysis Patients Receiving Erythropoietin: A Meta-Analysis Journal of the Medical Association of Thailand Chotmaihet thangphaet. ,vol. 94, pp. 134- ,(2011)
Angie Ghattas, Helen R. Griffiths, Andrew Devitt, Gregory Y.H. Lip, Eduard Shantsila, Monocytes in Coronary Artery Disease and Atherosclerosis Journal of the American College of Cardiology. ,vol. 62, pp. 1541- 1551 ,(2013) , 10.1016/J.JACC.2013.07.043
Paula Dutka, Erythropoiesis-stimulating agents for the management of anemia of chronic kidney disease: past advancements and current innovations Nephrology nursing journal : journal of the American Nephrology Nurses' Association. ,vol. 39, pp. 447- 457 ,(2012)
T G Hall, V Bennett, Regulatory domains of erythrocyte ankyrin Journal of Biological Chemistry. ,vol. 262, pp. 10537- 10545 ,(1987) , 10.1016/S0021-9258(18)60995-0
Marlene SB Gonçalves, Bruno A Fabris, Francis F Brinholi, Chiara C Bortolasci, Maria AE Watanabe, Karen B Oliveira, Vinícius DA Delfino, Edson L Lavado, Décio S Barbosa, None, Increased oxidative stress in foam cells obtained from hemodialysis patients Hemodialysis International. ,vol. 17, pp. 266- 274 ,(2013) , 10.1111/J.1542-4758.2012.00736.X
Jonathan Himmelfarb, Oxidative stress in hemodialysis Contributions To Nephrology. ,vol. 161, pp. 132- 137 ,(2008) , 10.1159/000130658
Clara Ersson, Ingegerd Odar‐Cederlöf, Ingela Fehrman‐Ekholm, Lennart Möller, The effects of hemodialysis treatment on the level of DNA strand breaks and oxidative DNA lesions measured by the comet assay. Hemodialysis International. ,vol. 17, pp. 366- 373 ,(2013) , 10.1111/HDI.12008
Min Jun, Vinod Venkataraman, Mona Razavian, Bruce Cooper, Sophia Zoungas, Toshiharu Ninomiya, Angela C Webster, Vlado Perkovic, Antioxidants for chronic kidney disease Cochrane Database of Systematic Reviews. ,vol. 10, pp. 1- 62 ,(2012) , 10.1002/14651858.CD008176.PUB2
Mayuri Thakuria, Norma J. Ofsthun, Claudy Mullon, Jose A. Diaz-Buxo, Anemia Management in Patients Receiving Chronic Hemodialysis Seminars in Dialysis. ,vol. 24, pp. 597- 602 ,(2011) , 10.1111/J.1525-139X.2011.00975.X